Poindexter BB, Feng R, Schmidt B, Aschner JL, Ballard RA, Hamvas A, et al. Comparisons and limitations of current definitions of bronchopulmonary dysplasia for the prematurity and respiratory outcomes program. Ann Am Thorac Soc. 2015;12:1822–30.
Article PubMed PubMed Central Google Scholar
Higgins RD, Jobe AH, Koso-Thomas M, Bancalari E, Viscardi RM, Hartert TV, et al. Bronchopulmonary dysplasia: executive summary of a workshop. J Pediatr. 2018;197:300–8.
Article PubMed PubMed Central Google Scholar
Ramel SE, Demerath EW, Gray HL, Younge N, Boys C, Georgieff MK. The relationship of poor linear growth velocity with neonatal illness and two-year neurodevelopment in preterm infants. Neonatology. 2012;102:19–24.
Guaman MC, Gien J, Baker CD, Zhang H, Austin ED, Collaco JM. Point prevalence, clinical characteristics, and treatment variation for infants with severe bronchopulmonary dysplasia. Am J Perinatol. 2015;32:960–7.
Article PubMed PubMed Central Google Scholar
Logan JW, Burdo-Hartman W, Lynch SK. Optimizing neurodevelopment in severe bronchopulmonary dysplasia. NeoReviews. 2017;18:e598–605.
Bauer SE, Schneider L, Lynch SK, Malleske DT, Shepherd EG, Nelin LD. Factors associated with neurodevelopmental impairment in bronchopulmonary dysplasia. J Pediatr. 2020;218:22–7.e2.
Article CAS PubMed Google Scholar
Logan JW, Lynch SK, Curtiss J, Shepherd EG. Clinical phenotypes and management concepts for severe, established bronchopulmonary dysplasia. Paediatr Respir Rev. 2019;31:58–63.
Keilt MJ, Logan JW, Backes CH, Reber KM, Nelin LD, Shepherd EG. In-hospital outcomes of later referrals for established bronchopulmonary dysplasia. J Perinatol. 2021;41:1972–82.
Vento G, Tirone C, Paladini A, Lio A, Tana M. Weaning from the ventilator in bronchopulmonary dysplasia. Clin Perinatol. 2021;48:895–906.
Pfister KM, Ramel SE. Linear growth and neurodevelopmental outcomes. Clin Perinatol. 2014;41:309–21.
Sanchez-Solis M, Perez-Fernandez V, Bosch-Gimenez V, Quesada JJ, Garcia-Marcos L. Lung function gain in preterm infants with and without bronchopulmonary dysplasia. Pediatr Pulmonol. 2016;51:936–42.
Abman SH, Collaco JM, Shepherd EG, Keszler M, Cuevas-Guaman M, Welty SE, et al. Interdisciplinary care of children with severe bronchopulmonary dysplasia. J Pediatr. 2017;181:12–28.e1.
Boateng GO, Neilands TB, Frongillo EA, Melgar-Quiñonez HR, Young SL. Best practices for developing and validating scales for health, social, and behavioral research: a primer. Front Public Health. 2018;6:149 https://doi.org/10.3389/fpubh.2018.00149.
Article PubMed PubMed Central Google Scholar
Natarajan G, Johnson YR, Brozanski B, Farrow KN, Zaniletti I, Padula MA, et al. Postnatal weight gain in preterm infants with severe bronchopulmonary dysplasia. Am J Perinatol. 2014;31:223–30.
Meyers JM, Tan S, Bell EF, Duncan AF, Guillet R, Stoll BJ, et al. Neurodevelopmental outcomes among extremely premature infants with linear growth restriction. J Perinatol. 2019;39:193–202.
Article CAS PubMed Google Scholar
Lagatta JM, Hysinger EB, Zaniletti I, Wymore EM, Vyas-Read S, Yallapragada S, et al. The impact of pulmonary hypertension in preterm infants with severe bronchopulmonary dysplasia through 1 year. J Pediatr. 2018;203:218–24.e3.
Article PubMed PubMed Central Google Scholar
Cuestas E, Aguilera B, Cerutti M, Rizzotti A. Sustained neonatal inflammation is associated with poor growth in infants born very preterm during the first year of life. J Pediatr. 2019;205:91–7.
Stavrou S, Nicolaides NC, Critselis E, Darviri C, Charmandari E, Chrousos GP. Paediatric stress: from neuroendocrinology to contemporary disorders. Eur J Clin Investig. 2017;47:262–9.
Gardelis JG, Hatzis TD, Stamogiannou LN, Dona AA, Fotinou AD, Brestas PS, et al. Activity of the growth hormone/insulin-like growth factor-I axis in critically ill children. J Pediatr Endocrinol Metab. 2005;18:363–72.
Article CAS PubMed Google Scholar
Gelato MC. The growth hormone/insulin-like growth factor axis in critical illness. J Pediatr Endocrinol Metab. 2000;13:S1023–9.
Van Dokkum NH, de Kroon MLA, Reijneveld SA, Bos AF. Neonatal stress, health, and development in preterms: a systematic review. Pediatrics. 2021;148:e202105414.
Yaribeygi H, Panahi Y, Sahraei H, Johnston TP, Sahebkar A. The impact of stress on body function: a review. EXCLI J. 2017;16:1057–72.
PubMed PubMed Central Google Scholar
Halliday HL. The effect of postnatal steroids on growth and development. J Perinat Med. 2001;29:281–5.
Article CAS PubMed Google Scholar
Balany J, Bhandari V. Understanding the impact of infection, inflammation, and their persistence in the pathogenesis of bronchopulmonary dysplasia. Front Med. 2015;2:90.
Thekkeveedu KR, Guaman MC, Shivanna B. Bronchopulmonary dysplasia: a review of pathogenesis and pathophysiology. Respir Med. 2017;132:170–7.
Article PubMed Central Google Scholar
Curtiss J, Zhang H, Griffiths P, Shepherd EG, Lynch S. Nutritional management of the infant with severe bronchopulmonary dysplasia. NeoReviews. 2015;16:e674–9.
Shepherd EG, Knupp AM, Welty SE, Susey KM, Gardner WP, Gest AL. An interdisciplinary bronchopulmonary dysplasia program is associated with improved neurodevelopmental outcomes and fewer rehospitalizations. J Perinatol. 2012;32:33–8.
留言 (0)